#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma recurrent Sickle cell anaemia Neurofibromatosis Rheumatoid arthritis Anal fistula Gastroenteropancreatic neuroendocrine tumour disease Adrenogenital syndrome Langerhans cell sarcoma Congenital megacolon MELAS syndrome Transient ischaemic attack Medullary thyroid cancer Undifferentiated sarcoma Bronchiectasis Cushing's syndrome More trials…

    Learn about Rare Diseases

    Brain stem glioma Gastrointestinal stromal tumour Small intestine leiomyosarcoma Hereditary angioedema – Treatment Mantle cell lymphoma stage III Osteosarcoma Waldenstrom’s macroglobulinaemia refractory – Diagnostics Angelman’s syndrome – Life with Disease Behcet’s syndrome – Trials in Disease Skin angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Jk08 ZELENECTIDE PEVEDOTIN Human Serum Albumin 5% KETOROLAC TROMETAMOL SAR444336 Tak-280 Gentamicin Mps-102 ATUMELNANT Eplontersen Izorlisib Mesilate Diclofenac Diethylamine L-Tyrosine Pazopanib Rituximab Pegfilgrastim Ranitidine Hydrochloride Emibetuzumab Bimatoprost Vosoritide More therapies…

    Learn about Your Condition

    Myocardial ischaemia Uterine cancer Urinary incontinence Petit mal epilepsy Breast cancer in situ Renal cell carcinoma stage IV Myxoid liposarcoma Myxofibrosarcoma Infantile spasms Hepatocellular carcinoma Pharyngeal cancer stage II Biliary tract disorder Cough Endometriosis Still's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal cancer

  • Study on the Impact of Exercise and Atorvastatin on Advanced Breast, Ovarian, Prostate, and Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cancer
    • Ovarian cancer metastatic
    • Prostate cancer metastatic
    Investigated Drugs:
    • Atorvastatin
    Finland

  • Study on Using EMI-137 for Intraoperative Visualization in Patients with Penile and Tongue Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Penile cancer
    • Renal cancer
    • Tongue neoplasm malignant stage unspecified
    Investigated Drugs:
    • Ac-Ala-Gly-Ser-Cys(1)-Tyr-Cys(2)-Ser-Gly-Pro-Pro-Arg-Phe-Glu-Cys(2)-Trp-Cys(1)-Tyr-Glu-Thr-Glu-Gly-Thr-Gly-Gly-Gly-Lys(Unk)-Nh2 Conjugated To Cy5 Dye
    The Netherlands

  • Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Bupivacaine Hydrochloride, Anhydrous
    • Extract Of Fresh Opium Poppy (1:2.2-2.7), Extraction Solvent: Ethanol 31.2 % (M/M)
    Sweden

  • Study of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study on Pain Relief and Recovery After Kidney Removal Surgery Using Ropivacaine, Dexamethasone, and Sodium Chloride in Patients with Renal Cancer

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Renal cancer
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Dexamethasone Sodium Phosphate
    • Sodium Chloride
    Finland

  • Study of Oncobax-AK with Immunotherapy for Patients with Advanced Non-Small Cell Lung Cancer or Renal Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • Akkermansia Muciniphila, Strain P2261, Live
    • Atezolizumab
    • Cemiplimab
    Belgium France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!